Targeting Sirt6: The Design And Therapeutic Implications Of Activators And Inhibitors

Aging Pathway
Therapeutic
The paper reviews recent advancements in developing molecules that can either boost or block the activity of a protein called SIRT6, which is important for maintaining health and is implicated in aging and various diseases.
Author

Gemini

Published

August 31, 2026

SIRT6 is a fascinating protein in our bodies that acts like a master regulator, influencing everything from how our cells repair their DNA to how our bodies process energy and even the aging process itself. Scientists are increasingly recognizing its critical role in maintaining overall health. Because of its widespread influence, controlling this protein’s activity offers exciting possibilities for treating a range of serious conditions. For instance, boosting its function could help combat age-related diseases and metabolic disorders like diabetes. Conversely, blocking its activity might be beneficial in certain types of cancer or inflammatory conditions. The challenge lies in the fact that this protein can sometimes play different roles depending on the specific cellular environment, meaning that precise targeting is crucial. Researchers are making significant strides in designing small molecules that can either activate or inhibit this protein. These molecules are like tiny keys designed to fit into specific locks on the protein, either turning its activity up or down. The goal is to create highly selective compounds that only affect this protein without interfering with other similar proteins, and that can be safely used as medicines. This ongoing work is vital for unlocking the full therapeutic potential of targeting this remarkable protein.


Source: link to paper